Paula de Robles

966 total citations
18 papers, 567 citations indexed

About

Paula de Robles is a scholar working on Genetics, Neurology and Epidemiology. According to data from OpenAlex, Paula de Robles has authored 18 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Paula de Robles's work include Glioma Diagnosis and Treatment (8 papers), Meningioma and schwannoma management (3 papers) and Autoimmune Neurological Disorders and Treatments (2 papers). Paula de Robles is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Meningioma and schwannoma management (3 papers) and Autoimmune Neurological Disorders and Treatments (2 papers). Paula de Robles collaborates with scholars based in Canada, Spain and United Kingdom. Paula de Robles's co-authors include Glòria Roldán, J. Gregory Cairncross, Sylvia Drabycz, Nathalie Jetté, Tamara Pringsheim, Alexandra Frolkis, Callie Atta, Kirsten M. Fiest, Darren Lam and Christine Smith and has published in prestigious journals such as Journal of Clinical Oncology, NeuroImage and Journal of Neurology.

In The Last Decade

Paula de Robles

14 papers receiving 553 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paula de Robles 285 172 109 103 93 18 567
Karra A. Jones 197 0.7× 209 1.2× 118 1.1× 106 1.0× 86 0.9× 37 624
Spyridon Voulgaris 426 1.5× 299 1.7× 84 0.8× 126 1.2× 93 1.0× 39 718
Anne Jarstein Skjulsvik 389 1.4× 205 1.2× 60 0.6× 122 1.2× 88 0.9× 16 513
Octavio Arevalo 170 0.6× 92 0.5× 104 1.0× 138 1.3× 85 0.9× 43 505
David Coope 255 0.9× 214 1.2× 59 0.5× 59 0.6× 126 1.4× 44 536
Grettel J. Zamora-Berridi 274 1.0× 77 0.4× 109 1.0× 75 0.7× 112 1.2× 14 566
Franziska Vettermann 324 1.1× 243 1.4× 73 0.7× 70 0.7× 101 1.1× 23 539
Yuzo Terakawa 353 1.2× 279 1.6× 90 0.8× 168 1.6× 129 1.4× 44 728
Aria Jamshidi 210 0.7× 77 0.4× 120 1.1× 78 0.8× 83 0.9× 44 524
Antonio Dono 330 1.2× 98 0.6× 193 1.8× 120 1.2× 59 0.6× 50 543

Countries citing papers authored by Paula de Robles

Since Specialization
Citations

This map shows the geographic impact of Paula de Robles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula de Robles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula de Robles more than expected).

Fields of papers citing papers by Paula de Robles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula de Robles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula de Robles. The network helps show where Paula de Robles may publish in the future.

Co-authorship network of co-authors of Paula de Robles

This figure shows the co-authorship network connecting the top 25 collaborators of Paula de Robles. A scholar is included among the top collaborators of Paula de Robles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula de Robles. Paula de Robles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Daun, Julia T., L Capozzi, Gloria Roldan Urgoiti, et al.. (2024). The feasibility of a multi-site, clinic-supported, and tailored neuro-oncology exercise program. Neuro-Oncology Practice. 12(1). 131–142. 2 indexed citations
2.
Kapadia, Ronak K., et al.. (2024). Long-Term Follow-Up of Non-Paraneoplastic Autoimmune Encephalitis: A Canadian Single-Center Experience. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 52(3). 392–398.
3.
Faye, Mame Daro, Jacob C. Easaw, Paula de Robles, et al.. (2023). Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma. Neuro-Oncology Advances. 5(1). vdad106–vdad106. 5 indexed citations
4.
Casault, Colin, et al.. (2020). Systematic review of the clinical spectrum of CASPR2 antibody syndrome. Journal of Neurology. 267(4). 1137–1146. 58 indexed citations
5.
Mason, Warren, Paula de Robles, Laura Borodyansky, et al.. (2017). BBI608-201GBM: A phase Ib/II clinical study of napabucasin (BBI608) in combination with temozolomide (TMZ) for adult patients with recurrent glioblastoma (GBM).. Journal of Clinical Oncology. 35(15_suppl). e13525–e13525. 7 indexed citations
6.
Parera, Ignacio Casas, et al.. (2016). Meningiomas en neurooncología. Neurología Argentina. 8(3). 210–226. 2 indexed citations
7.
Robles, Paula de, Kirsten M. Fiest, Alexandra Frolkis, et al.. (2014). The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro-Oncology. 17(6). 776–783. 226 indexed citations
8.
Mah, Jean K., Ruth Hall, Eric E. Smith, et al.. (2013). Evaluation of Neurological Patient Registries. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40(S2). S60–S61. 2 indexed citations
9.
Marriott, James, Vanessa K. Noonan, Elizabeth Donner, et al.. (2013). Neurological Registry Quality Control and Quality Assurance. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40(S2). S47–S50. 1 indexed citations
10.
Hogan, David B., Scott B. Patten, Lynn Dagenais, et al.. (2013). Ethical and Legal Considerations for Canadian Registries. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40(S2). S5–S22. 8 indexed citations
11.
Parera, Ignacio Casas, et al.. (2013). Tumores gliales del sistema nervioso: planificación y porcentaje de resección. Neurología Argentina. 5(2). 129–132.
12.
Parera, Ignacio Casas, et al.. (2012). Protocolo de estudio por neuroimágenes de los tumores del sistema nervioso central. Neurología Argentina. 5(1). 37–43. 1 indexed citations
13.
Drabycz, Sylvia, Glòria Roldán, Paula de Robles, et al.. (2009). An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. NeuroImage. 49(2). 1398–1405. 160 indexed citations
14.
Levner, Ilya, Sylvia Drabycz, Glòria Roldán, et al.. (2009). Predicting MGMT Methylation Status of Glioblastomas from MRI Texture. Lecture notes in computer science. 12(Pt 2). 522–530. 44 indexed citations
15.
Robles, Paula de, John B. McIntyre, Sanjog Kalra, et al.. (2008). Methylation status of MGMT gene promoter in meningiomas. Cancer Genetics and Cytogenetics. 187(1). 25–27. 23 indexed citations
16.
Chambers, Carole, et al.. (2008). A feasibility study to assess the integration of a pharmacist into neurooncology clinic. Journal of Oncology Pharmacy Practice. 15(2). 79–85. 17 indexed citations
17.
Robles, Paula de, et al.. (2005). Síndrome de leucoencefalopatía posterior reversible por cisplatino. Revista de Neurología. 41(9). 573–573. 5 indexed citations
18.
Juttmann, J.R., et al.. (1992). Safety of the Coadministration of Carvedilol and Nifedipine Sustained-Release in the Treatment of Essential Hypertension. Journal of Cardiovascular Pharmacology. 19(Supplement 1). S134–S137. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026